About: Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on March 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articol științific (ro) articolo scientifico (it) artigo científico (gl) artigo científico (pt) artigo científico (pt-br) artikull shkencor (sq) artículo científico (es) bilimsel makale (tr) scienca artikolo (eo) vedecký článok (sk) vetenskaplig artikel (sv) vitenskapelig artikkel (nb) vitskapeleg artikkel (nn) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научная статья (ru) научни чланак (sr) מאמר מדעי (he) artikel ilmiah (id) article scientifique (fr) বৈজ্ঞানিক নিবন্ধ (bn) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в березні 2013 (uk) مقالة علمية نشرت في مارس 2013 (ar) scientific article published on March 2013 (en) scientific article published on March 2013 (en-ca) scientific article published on March 2013 (en-gb) գիտական հոդված հրատարակված 2013 թվականի մարտին (hy)
publication date	wds:Q38087694-48C9DB67-6CD9-485C-93BB-A5045AC9D3E5
publication date	2013-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q38087694-3D402966-895C-46FF-AF7A-5FDE597FCBD1
language of work or name	English
cites work	wds:Q38087694-01867982-F353-4431-9161-7EBC58EA323A wds:Q38087694-02DC3032-09A6-42BA-BA71-6BC785E4AC82 wds:Q38087694-03E513C9-B6DF-46A6-B676-169091D400B6 wds:Q38087694-0BBC021F-BAAC-45B5-98AC-1733A8FC585A wds:Q38087694-12924C4C-CA6F-4445-9D9B-83358FE9D885 wds:Q38087694-15F660AD-5C88-411E-A5F1-340117C4B0A6 wds:Q38087694-183E945E-1DBA-469F-AAC0-77DB60BA79F9 wds:Q38087694-18E3C406-CB71-48BD-9E0D-9E6FFAE89E00 wds:Q38087694-359DBB75-78E2-487C-98F8-152009E563B9 wds:Q38087694-41F21963-2934-4F6F-ABE5-8FA0231AF8BA wds:Q38087694-45792682-693D-4F60-8436-67C690614774 wds:Q38087694-4A8FC3EF-1EF2-471B-A2D6-F618550D4E69 wds:Q38087694-553D8218-B9DC-4F90-BB99-2BD858DBDB6B wds:Q38087694-5B35B7A7-59BA-4C63-AF17-24B546C968EC wds:Q38087694-608B7D48-2FDB-4A58-9543-B9C053331BC0 wds:Q38087694-61728AE9-A5AA-44F9-9C46-3D8C86BBFB69 wds:Q38087694-6DEAD32D-9007-4D68-AC60-E9DAD2416E05 wds:Q38087694-782B5C97-380A-4869-8205-CA0B80B50767 wds:Q38087694-81804915-A650-4A00-BC9E-78A38C234557 wds:Q38087694-A9366692-B843-49B8-AFD5-97615AAC9FEE wds:Q38087694-ACA9AFA9-3AF7-440E-AA93-CC6D03F59C04 wds:Q38087694-B4C497AB-9EEA-478B-BFA0-9055F10EF7DB wds:Q38087694-C2139C5C-2AF8-49B8-820B-D7FC58CCF370 wds:Q38087694-CBE41DD4-0053-4458-A2E8-B337D20C8D6F wds:Q38087694-DD78A344-793B-4C5D-AF74-A17E61E339FE wds:Q38087694-E9587148-5E69-4583-B356-021B7438FF7C wds:Q38087694-EFE84FF6-F3DA-46D8-B5D2-D00AA1A8F6F3 wds:Q38087694-FC7E3132-2207-4125-9F33-F66FCC7F76CD
cites work	Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France wd:Q24812856 Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis Tocilizumab: the first interleukin-6-receptor inhibitor Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis The IL-6/sIL-6R complex as a novel target for therapeutic approaches Targeting interleukin-6 in pediatric rheumatic diseases Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience Recognition and management of macrophage activation syndrome in juvenile arthritis Humanized antihuman IL-6 receptor antibody, tocilizumab Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis. Update on the pathogenesis and treatment of systemic idiopathic arthritis Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis Human liver progenitor cell lines are readily established from non-tumorous tissue adjacent to hepatocellular carcinoma Current treatments for juvenile idiopathic arthritis Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.
author name string	wds:Q38087694-59A74A9D-A1BF-479E-99FA-8BE6FB095BDA wds:Q38087694-6B0F0451-1231-4B39-A134-C23B5EBABC31 wds:Q38087694-793DCFE3-BD2D-4B93-B2D3-2A98C5E5E82D wds:Q38087694-CE8FF791-DB27-4618-90C6-50208A8FFAB5
author name string	Xiaoping Zhang Tomohisa Saito Peter N Morcos Kimio Terao

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software